Previous 10 | Next 10 |
Gainers: NovaBay Pharmaceuticals (NYSEMKT: NBY ) +34% . Medley Management (NYSE: MDLY ) +33% . Pieris Pharmaceuticals (NASDAQ: PIRS ) +24% . Daxor (NYSEMKT: DXR ) +18% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +17% . Acasti Pharma (NASDAQ: ACST ) +15% . Mylan N.V. (NASDAQ: MYL...
Pieris Pharmaceuticals ( PIRS +14.5% ) is up on a 4x surge in volume in apparent response to a bullish note from William Blair's Matt Phipps who says its inhaled PRS-060 should be a winner in patients with severe asthma. More news on: Pieris Pharmaceuticals, Inc., Healthcare stocks news,...
Medley Management (NYSE: MDLY ) +35% as Sierra, Medley Capital, Medley Management amend merger deals . More news on: Medley Management Inc., Sintx Technologies, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...
BOSTON, MA / ACCESSWIRE / July 25, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for respiratory diseases, cancer and other indications, today announced ...
BOSTON, MA / ACCESSWIRE / May 30, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory, cancer and other diseases, announced today that Stephen ...
The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) stayed in the green again last week, rising from 3,234.74 points on Monday (May 20) to 3,280.05 points as of 1:02 p.m. EDT on Friday (May 24). In terms of biotech and pharma stocks, last week shares of Sesen Bio (NASDAQ: SESN ) jumped ...
Gainers: Avianca Holdings (NYSE: AVH ) +29% . Outlook Therapeutics (NASDAQ: OTLK ) +28% . Hibbett Sports (NASDAQ: HIBB ) +21% . Total System Services (NYSE: TSS ) +16% . Cavco Industries (NASDAQ: CVCO ) +16% . Biocept (NASDAQ: BIOC ) +13% . DASAN Zhone Solutions (NASDAQ: DZSI )...
BOSTON, MA / ACCESSWIRE / May 22, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced t...
CymaBay Therapeutics (NASDAQ: CBAY ) initiated with Buy rating and $21 (70% upside) price target at Citigroup. Shares up 1% premarket. More news on: CymaBay Therapeutics, Inc., MannKind Corporation, Pieris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , ...
BOSTON, MA / ACCESSWIRE / May 14, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory, cancer and other diseases, announced today that Allan Re...
News, Short Squeeze, Breakout and More Instantly...
Pieris Pharmaceuticals Inc. Company Name:
PIRS Stock Symbol:
NASDAQ Market:
Pieris Pharmaceuticals Inc. Website:
2024-07-27 03:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 75.8% to $0.0457 on volume of 1,196,767,473 shares NVIDIA Corporation (NVDA) fell 6.8% to $114.25 on volume of 316,196,296 shares Sangamo Therapeutics Inc. (SGMO) rose 39.5% to $0.56 on volume of 261...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...